PIV5 has been commonly administered to dogs as part of combination distemper/kennel cough vaccines for decades. Blue Lake Biotechnology is developing BLB201 as an intranasal vaccine to prevent ...
December 09, 2024--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal ... administered to dogs as part of combination distemper/kennel cough vaccines ...